CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- 4 Grant or award EVP and Chief Medical Officer acquired 39,147 shares (grant or award)
- 4 Grant or award EVP & Chief Commercial Officer acquired 51,945 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 51,889 shares (grant or award)
- 4 Open-market sale EVP and General Counsel sold 6,081 shares at $24.45 ($148,680)
- 4 Grant or award Executive Vice President & CFO acquired 50,161 shares (grant or award)
- 4 Grant or award President and CEO acquired 133,989 shares (grant or award)
- 4 Open-market sale EVP & Chief Commercial Officer sold 1,322 shares at $22.89 ($30,261)
- 4 Shares withheld for taxes EVP & Chief Commercial Officer gave up 701 shares (to pay taxes)
- 4 Open-market sale Chief Technology Officer sold 19,378 shares at an average $22.17 ($429,652)
- 4 Shares withheld for taxes President and CEO gave up 1,090 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 4 Open-market sale Chief Technology Officer sold 5,967 shares at $19.24 ($114,805)
- 4 Shares withheld for taxes President and CEO gave up 4,672 shares (to pay taxes)
- 4 Option exercise Chief Technology Officer acquired 16,000 shares (option exercise)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market sale EVP and General Counsel sold 7,060 shares at $20.82 ($146,989)
- 8-K Event Material agreement · Other events
- 4 Grant or award Director acquired 5,027 shares (grant or award)
Page 23 of 44 · 872 filings